Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Mar 2;7(2):e00336.
doi: 10.14309/crj.0000000000000336. eCollection 2020 Feb.

Vanishing Bile Duct Syndrome Preceding the Diagnosis of Hodgkin Lymphoma

Affiliations
Case Reports

Vanishing Bile Duct Syndrome Preceding the Diagnosis of Hodgkin Lymphoma

Chimaobi Anugwom et al. ACG Case Rep J. .

Abstract

Vanishing bile duct syndrome is an acquired liver disease characterized by the progressive destruction and loss of intrahepatic bile ducts. It usually signifies end-stage cholestatic liver disease and is characterized by ductopenia on liver biopsy specimen. We present a case of vanishing bile duct syndrome as the presenting symptom in a patient with Hodgkin lymphoma with subsequent improvement after adequate treatment of the lymphoma.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Liver biopsy showing the absence of native bile duct using hematoxylin and eosin stain (A) and cytokeratin 7 (B and C).
Figure 2.
Figure 2.
Trend of liver enzymes with chemotherapy for Hodgkin lymphoma. ALP, alkaline phosphatase; ALT, alanine transaminase; AST, aspartate transaminase.

References

    1. Nakanuma Y, Tsuneyama K, Harada K. Pathology and pathogenesis of intrahepatic bile duct loss . J Hepatobiliary Pancreat Surg. 2001;8(4):303–15. - PubMed
    1. Bakhit M, McCarty TR, Park S, et al. Vanishing bile duct syndrome in Hodgkin's lymphoma: A case report and literature review . World J Gastroenterol. 2017;23(2):366–72. - PMC - PubMed
    1. Ludwig J, Wiesner RH, LaRusso NF, Idiopathic adulthood ductopenia. A cause of chronic cholestatic liver disease and biliary cirrhosis . J Hepatol. 1988;7(2):193–9. - PubMed
    1. Geubel AP, Sempoux CL. Drug and toxin-induced bile duct disorders . J Gastroenterol Hepatol. 2000;15(11):1232–8. - PubMed
    1. Kita H, Matsumura S, He XS, et al. Quantitative and functional analysis of PDC-E2-specific autoreactive cytotoxic T lymphocytes in primary biliary cirrhosis . J Clin Invest. 2002;109(9):1231–40. - PMC - PubMed

Publication types